Belén Herrero, PhD performed her studies at the University of Buenos Aires, Argentina. She was actively involved in the research aspects of reactive oxygen species (ROS) in sperm function. During her PhD, she characterized the presence of the enzyme responsible for synthesizing nitric oxide in mouse and human sperm, emphasizing the controversial concept that small concentrations of ROS are important for sperm function. Her research allowed other scientists to continue further discoveries in this field.
Belén Herrero was then awarded a fellowship from the National Institutes of Health (NIH) to perform her postdoctoral studies in the Urology Research Lab at McGill University. She was also a recipient of a Berlex-Schering fellowship that allowed her to perform her second postdoctoral studies at the University of Virginia.
After several years of research in the field of fertilization and gamete interaction, Belén Herrero joined the MUHC-Reproductive Centre in Montreal as Andrology Supervisor, where she was involved in planning and developing an andrology laboratory and sperm cryo bank for cancer patients.
Because of her strong interest in improving patient care, she became surveyor of Accreditation Canada and also applied to the Rossy Cancer Network Quality Improvement Initiative (QI2) Grants, where she was recipient of the 2015 and 2017 competitions. The aim of the grants was to improve knowledge and awareness to health care providers and patients with cancer on fertility preservation. She was an invited speaker in several occasions, has a total of 34 refereed publications, and is a peer reviewer for the journals: Andrology, Journal of Assisted Reproduction and Genetics, Human Reproduction Update and Journal of Patience Experience.